Tammy Sobolik
Last active: 6/14/2013

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence. Liu Y, Hawkins OE, Su Y, Vilgelm AE, Sobolik T, Thu YM, Kantrow S, Splittgerber RC, Short S, Amiri KI, Ecsedy JA, Sosman JA, Kelley MC, Richmond A (2013) EMBO Mol Med 5(1): 149-66
    › Citation · 23180582 (PubMed) · PMC3569660 (PubMed Central)
  2. Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials. Lovly CM, Dahlman KB, Fohn LE, Su Z, Dias-Santagata D, Hicks DJ, Hucks D, Berry E, Terry C, Duke M, Su Y, Sobolik-Delmaire T, Richmond A, Kelley MC, Vnencak-Jones CL, Iafrate AJ, Sosman J, Pao W (2012) PLoS One 7(4): e35309
    › Citation · 22536370 (PubMed) · PMC3335021 (PubMed Central)
  3. RAF265 inhibits the growth of advanced human melanoma tumors. Su Y, Vilgelm AE, Kelley MC, Hawkins OE, Liu Y, Boyd KL, Kantrow S, Splittgerber RC, Short SP, Sobolik T, Zaja-Milatovic S, Dahlman KB, Amiri KI, Jiang A, Lu P, Shyr Y, Stuart DD, Levy S, Sosman JA, Richmond A (2012) Clin Cancer Res 18(8): 2184-98
    › Citation · 22351689 (PubMed) · PMC3724517 (PubMed Central)
  4. IQGAP1 is a novel CXCR2-interacting protein and essential component of the "chemosynapse". Neel NF, Sai J, Ham AJ, Sobolik-Delmaire T, Mernaugh RL, Richmond A (2011) PLoS One 6(8): e23813
    › Citation · 21876773 (PubMed) · PMC3158102 (PubMed Central)
  5. Chemokines in health and disease. Raman D, Sobolik-Delmaire T, Richmond A (2011) Exp Cell Res 317(5): 575-89
    › Citation · 21223965 (PubMed) · PMC3063402 (PubMed Central)
  6. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Rhodes LV, Short SP, Neel NF, Salvo VA, Zhu Y, Elliott S, Wei Y, Yu D, Sun M, Muir SE, Fonseca JP, Bratton MR, Segar C, Tilghman SL, Sobolik-Delmaire T, Horton LW, Zaja-Milatovic S, Collins-Burow BM, Wadsworth S, Beckman BS, Wood CE, Fuqua SA, Nephew KP, Dent P, Worthylake RA, Curiel TJ, Hung MC, Richmond A, Burow ME (2011) Cancer Res 71(2): 603-13
    › Citation · 21123450 (PubMed) · PMC3140407 (PubMed Central)
  7. Plakophilin-1 localizes to the nucleus and interacts with single-stranded DNA. Sobolik-Delmaire T, Reddy R, Pashaj A, Roberts BJ, Wahl JK (2010) J Invest Dermatol 130(11): 2638-46
    › Citation · 20613778 (PubMed)
  8. VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis. Neel NF, Barzik M, Raman D, Sobolik-Delmaire T, Sai J, Ham AJ, Mernaugh RL, Gertler FB, Richmond A (2009) J Cell Sci 122(Pt 11): 1882-94
    › Citation · 19435808 (PubMed) · PMC2684839 (PubMed Central)
  9. Short tail with skin lesion phenotype occurs in transgenic mice with keratin-14 promoter-directed expression of mutant CXCR2. Yu Y, Su Y, Opalenik SR, Sobolik-Delmaire T, Neel NF, Zaja-Milatovic S, Short ST, Sai J, Richmond A (2008) J Leukoc Biol 84(2): 406-19
    › Citation · 18505935 (PubMed) · PMC2493076 (PubMed Central)
  10. The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells. Dhawan P, Su Y, Thu YM, Yu Y, Baugher P, Ellis DL, Sobolik-Delmaire T, Kelley M, Cheung TC, Ware CF, Richmond A (2008) J Biol Chem 283(22): 15399-408
    › Citation · 18347013 (PubMed) · PMC2397477 (PubMed Central)
  11. Decreased plakophilin-1 expression promotes increased motility in head and neck squamous cell carcinoma cells. Sobolik-Delmaire T, Katafiasz D, Keim SA, Mahoney MG, Wahl JK (2007) Cell Commun Adhes 14(2-3): 99-109
    › Citation · 17668353 (PubMed)
  12. Carboxyl terminus of Plakophilin-1 recruits it to plasma membrane, whereas amino terminus recruits desmoplakin and promotes desmosome assembly. Sobolik-Delmaire T, Katafiasz D, Wahl JK (2006) J Biol Chem 281(25): 16962-70
    › Citation · 16632867 (PubMed)